Medline slips as sponsors look to cut stake in secondary offering

By Reuters News

** Medical supplies giant Medline's MDLN.O shares fall 4.6% to $37.65 premarket

** MDLN announces launch of 60-million-share secondary offering by certain selling stockholders including Blackstone BX.N, Carlyle Group CG.O, Hellman & Friedman, GIC Private and Abu Dhabi Investment Authority

** Blackstone and H&F offloading 19 million shares each, while Carlyle is selling 9.5 million shares

** Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are acting as global coordinators and joint bookrunning managers, and Blackstone Capital Markets and Carlyle are acting as co-managers for offering

** MDLN has also agreed to buy roughly $200 million of shares and common units from selling stockholders in a private, non-underwritten transaction

** Co has 1.31 billion outstanding shares, according to prospectus

** 22 of 28 brokerages rate the stock "buy" or higher and 6 "hold"; median PT $46

** As of last close, MDLN stock down 6% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.